Table of contents

  • Preliminary material
    • Title and verso pages
    • Contents
    • Preface
    • Acknowledgments
    • Abbreviations and symbols
    • Summary1
  • Body section
    1. Introduction
      1. Background
      2. Context
      3. Delivery and financing of health services
      4. Definitions and concepts
      5. Data quality and limitations
        • Data sources
        • Quality of expenditure estimates
        • Quality of data on Aboriginal and Torres Strait Islander service use
      6. Economies of scale and geographic isolation
      7. Key definitions
    2. Population, health status and incomes of Aboriginal and Torres Strait Islander people
      1. Aboriginal and Torres Strait Islander population
      2. Aboriginal and Torres Strait Islander health status
      3. Aboriginal and Torres Strait Islander incomes
    3. Total expenditure and funding
      1. Total health and residential aged care expenditure
        • Total health expenditure
      2. Total health funding
      3. Australian Government funding
      4. Funding by state and territory governments
    4. Government and non-government expenditure
      1. Direct expenditure by the Australian Government
      2. Medicare and the Pharmaceutical Benefits Scheme
      3. Expenditure by state and territory governments
      4. Non-government
      5. Expenditure by program management
        • Program management
        • Expenditure levels by program
        • Expenditure patterns
    5. Expenditure on primary and secondary/tertiary health services
    6. Changes over time
  • End matter
    • Appendixes
      1. Methodology
        1. Scope
          • Definition of health expenditure
          • Classification of areas of health expenditure
          • Public hospital and public hospital services expenditure
          • Primary and secondary/tertiary care
        2. Sources of data and methods of estimation of Aboriginal and Torres Strait Islander proportion
          • Hospital costs
          • Community health services
          • Medicare Benefits Schedule and the Pharmaceutical Benefits Scheme
        3. Deflation and constant price expenditure aggregates
      2. Summary of the use of Medicare’s Voluntary Indigenous Identifier
        • Medicare Voluntary Indigenous Identifier data
          • Use of VII data in the 2006–07 report
          • Method of estimating benefits paid and fees paid for services provided to Aboriginal and Torres Strait Islander patients
    • References
    • List of tables
    • List of figures
    • List of boxes

  1. Notes and corrections